A Novel Community-Based Buprenorphine Program Client Description and Initial Outcomes

被引:16
作者
Daniels, Amy M. [1 ]
Salisbury-Afshar, Elizabeth [2 ]
Hoffberg, Adam [3 ]
Agus, Deborah [2 ,3 ]
Fingerhood, Michael I. [4 ]
机构
[1] Autism Speaks, New York, NY USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Behav Hlth Leadership Inst, Baltimore, MD USA
[4] Johns Hopkins Univ, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA
关键词
opiate; recovery; buprenorphine; transition; community; UNITED-STATES; COST-EFFECTIVENESS; DRUG-USE; METHADONE; PREVALENCE; THERAPY;
D O I
10.1097/ADM.0000000000000004
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The aims of this retrospective, descriptive study were to describe clients served by a buprenorphine program in a community-based recovery center and to present initial treatment outcomes. A record review was conducted for clients treated from July 2010 to August 2011. Client demographic, health, substance use, and treatment history data were abstracted from the records of the first 78 clients served. Buprenorphine and opiate use data were collected via urine toxicology reports, collected weekly among clients who remained enrolled in treatment. The average percentages of weeks spent opiate free and buprenorphine compliant were 83% (SD = 26%) and 95% (SD = 13%), respectively. When positive heroin toxicology and negative buprenorphine toxicology were replaced for the missing/unknown data, the average percentages of opiate-abstinent weeks and buprenorphine compliance were 60% (SD = 34%) and 74% (SD = 28%), respectively. Roughly half of all clients (49%) were successfully transitioned to continue treatment with buprenorphine in a primary care setting. Findings from this study demonstrate that buprenorphine treatment for opiate dependence can be incorporated into a community-based recovery center with high rates of opiate abstinence and treatment adherence.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 19 条
[1]   Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004 [J].
Amon, Joseph J. ;
Garfein, Richard S. ;
Ahdieh-Grant, Linda ;
Armstrong, Gregory L. ;
Ouellet, Lawrence J. ;
Latka, Mary H. ;
Vlahov, David ;
Strathdee, Steffanie A. ;
Hudson, Sharon M. ;
Kerndt, Peter ;
Jarlais, Don Des ;
Williams, Ian T. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1852-1858
[2]  
[Anonymous], NSDUH REP ILL DRUG U
[3]  
[Anonymous], MED PRIM
[4]  
[Anonymous], 2012, NSDUH SER
[5]  
[Anonymous], 2 BALT SUBST AB SYST
[6]   A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence [J].
Barnett, PG ;
Rodgers, JH ;
Bloch, DA .
ADDICTION, 2001, 96 (05) :683-690
[7]   The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States [J].
Barnett, PG ;
Zaric, GS ;
Brandeau, ML .
ADDICTION, 2001, 96 (09) :1267-1278
[8]   Opioid use disorder in the United States: Insurance status and treatment access [J].
Becker, William C. ;
Fiellin, David A. ;
Merrill, Joseph O. ;
Schulman, Beryl ;
Finkelstein, Ruth ;
Olsen, Yngvild ;
Busch, Susan H. .
DRUG AND ALCOHOL DEPENDENCE, 2008, 94 (1-3) :207-213
[9]   Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago [J].
Boodram, Basmattee ;
Golub, Elizabeth T. ;
Ouellet, Lawrence J. .
DRUG AND ALCOHOL DEPENDENCE, 2010, 111 (1-2) :136-145
[10]  
Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1